ST葫芦娃：小儿肺热咳喘颗粒获得药物临床试验批准通知书

Core Viewpoint - ST HuLuWa (605199.SH) has received approval from the National Medical Products Administration for clinical trials of its pediatric lung heat cough and asthma granules, indicating a significant step in the development of this product [1] Company Summary - The clinical trial approval pertains to the improved formulation of the already marketed "Pediatric Lung Heat Cough and Asthma Granules" (National Drug Approval Number Z20033152) [1] - The new formulation aims to expand the therapeutic indications to include "lung heat syndrome caused by influenza" in addition to its original functions [1]